Abstract
Improving indoor air quality is one potential strategy to reduce the transmission of SARS-CoV-2 in any setting, including nursing homes, where staff and residents have been disproportionately and negatively affected by the COVID-19 pandemic. We used an interrupted time series design to compare trends in weekly COVID-19 cases and deaths before and after installation of ultraviolet air purification in 84 nursing homes in Florida, Georgia, North Carolina, and South Carolina from September 31, 2020 to December 27, 2020. Compared to pre-installation, weekly COVID-19 cases per 1,000 residents (−1.69, 95%CI: -4.32, 0.95) and the weekly probability of reporting any COVID-19 case (−0.02, 95%CI: -0.04, 0.00) declined in the post-installation period. We did not find any difference pre- and post-installation in COVID-19-related mortality (0.00 95%CI: -0.01, 0.02). Our findings from this small number of nursing homes in the southern US demonstrate the potential benefits of air purification in nursing homes on COVID-19 outcomes. We recommend a stronger experimental design to estimate the causal effect of installing air purification devices like this one on improving COVID-19 outcomes in nursing homes.
Practical Implications Improving indoor air quality is one potential strategy to reduce the burden of COVID-19 in nursing homes and nursing homes are eligible to receive Civil Monetary Penalty funding for purchases that improve air quality. Intervening on air quality may have a wide impact without placing significant burden on individuals to modify their behavior. In this pilot evaluation, we found that installing ultraviolet air purification may be an effective strategy to reduce COVID-19 cases in nursing homes. We recommend a stronger experimental design to determine the causal effect of indoor air interventions, such as air purification, on COVID-19 in this setting.
Competing Interest Statement
Joseph M. Braun was financially compensated for his services as an expert witness for plaintiffs in litigation related to PFAS-contaminated drinking water. The other authors report no conflicts of interest.
Funding Statement
This work was supported by RGF Environmental Group, Inc., manufacturer of the air purifiers. The evaluation was conducted independently and the contents are solely those of the authors. We thank RGF for funding; the nursing home corporation that installed the air purifiers for permission to use their installation data; and Smart Air Care, the distributor, for providing those data.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Because this was a retrospective evaluation and did not involve any resident-level data, it did not require patient consent and was not considered human subjects research or subject to Institutional Review Board approval.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding / Conflict of Interest: This work was supported by RGF Environmental Group, Inc., manufacturer of the air purifiers. The evaluation was conducted independently and the contents are solely those of the authors. We thank RGF for funding; the nursing home corporation that installed the air purifiers for permission to use their installation data; and Smart Air Care, the distributor, for providing those data. Joseph M. Braun was financially compensated for his services as an expert witness for plaintiffs in litigation related to PFAS-contaminated drinking water. The other authors report no conflicts of interest.
Ethical Approval: Because this was a retrospective evaluation and did not involve any resident-level data, it did not require patient consent and was not considered human subjects research or subject to Institutional Review Board approval.
Data availability: Public data used in analyses are directly available from the sources or the authors. We linked public data with private data from a multi-facility nursing home corporation in the southern US that gave permission for the distributor (Smart Air Care) of the ultraviolet air purification system that they installed to share facility-level data for this evaluation.
Data Availability
Public data used in analyses are directly available from the sources or the authors. We linked public data with private data from a multi-facility nursing home corporation in the southern US that gave permission for the distributor (Smart Air Care) of the ultraviolet air purification system that they installed to share facility-level data for this evaluation.
